ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Infectious Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,048Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 33

$992K Total Retail Price of All Prescriptions

Rank: 2 out of 33

702 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 702 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

14% of this provider’s 702 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 11,567 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 42%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $255 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 540 461 1 4
LISINOPRIL 505 428 2 3
FUROSEMIDE 480 404 3 9
HYDROCODONE-ACETAMINOPHEN 455 297 S3 4 11
SIMVASTATIN 449 401 5 5
AMLODIPINE BESYLATE 438 404 6 7
POTASSIUM CHLORIDE 354 282 7 17
WARFARIN SODIUM 352 319 8 12
OMEPRAZOLE 324 241 9 6
ATENOLOL 291 275 10 14
GABAPENTIN 230 176 11 18
ZOLPIDEM TARTRATE 211 180 12 27
CEFADROXIL 191 114 13 34
ALLOPURINOL 188 153 14 30
ALENDRONATE SODIUM 177 151 15 29
SERTRALINE HCL 173 166 16 36
ATORVASTATIN CALCIUM 164 97 17 22
HYDROCHLOROTHIAZIDE 159 156 18 10
PREDNISONE 153 95 19 33
CIPROFLOXACIN HCL 151 125 20 40
METOPROLOL TARTRATE 149 133 21 15
METOPROLOL SUCCINATE 133 118 22 21
CARVEDILOL 132 122 23 46
CLOPIDOGREL 128 100 24 47
METFORMIN HCL 119 103 25 23
LOVASTATIN 118 106 26 32
TRIAMTERENE-HCTZ 117 107 27 48
MELOXICAM 115 72 28 49
GEMFIBROZIL 105 80 29 37
ADVAIR DISKUS 102 51 30 51
METFORMIN HCL ER 102 77 30 51
CITALOPRAM HBR 102 86 30 31
PLAVIX 100 86 33 53
DOXYCYCLINE HYCLATE 98 44 34 20
AZITHROMYCIN 94 68 35 55
LOSARTAN POTASSIUM 91 80 36 25
HYDRALAZINE HCL 89 73 37 56
PANTOPRAZOLE SODIUM 89 69 37 39
LANTUS 87 69 39 58
SYNTHROID 87 84 39 58
SULFAMETHOXAZOLE-TRIMETHOPRIM 86 54 41 24
DONEPEZIL HCL 86 86 41 60
PRAVASTATIN SODIUM 80 61 43 19
FLUCONAZOLE 80 51 43 61
CLONIDINE HCL 80 63 43 61
TERAZOSIN HCL 77 72 46 63
NEXIUM 76 42 47 64
OXYBUTYNIN CHLORIDE 71 53 48 65
NITROFURANTOIN 71 64 48 65
PAROXETINE HCL 69 49 50 69
KLOR-CON M20 69 66 50 69
DIGOXIN 68 66 52 41
POLYETHYLENE GLYCOL 3350 66 49 53 73
PREMARIN 64 63 R 54 76
CYCLOBENZAPRINE HCL 64 28 R 54 76
ORPHENADRINE CITRATE 61 32 R 56 79
BUPROPION XL 61 47 56 79
METOLAZONE 61 46 56 79
LIPITOR 61 37 56 79
INSULIN SYRINGE 60 44 60 83
AMOXICILLIN 60 47 60 83
FLUOXETINE HCL 60 47 60 35
NAMENDA 58 58 63 86
RANITIDINE HCL 56 56 64 88
TAMSULOSIN HCL 55 55 65 90
OXYCODONE HCL 54 22 S2 66 44
RIFAMPIN 52 31 67 50
ENALAPRIL MALEATE 52 52 67 94
TRAMADOL HCL 51 42 69 96
METHYLPHENIDATE HCL 50 42 70 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.